Interest and other income
Search documents
Ahead of Ventas (VTR) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2026-02-03 15:16
Core Insights - Wall Street analysts anticipate Ventas (VTR) will report quarterly earnings of $0.89 per share, reflecting a year-over-year increase of 9.9% [1] - Expected revenues for Ventas are projected at $1.49 billion, which represents a 16.1% increase from the same quarter last year [1] - There has been a slight downward revision of 0.2% in the consensus EPS estimate over the last 30 days, indicating a reassessment by analysts [1] Revenue Estimates - Analysts estimate 'Revenues- Interest and other income' will reach $2.25 million, indicating a significant year-over-year decline of 72.9% [4] - The 'Revenues- Rental income- Outpatient medical & research portfolio' is projected to be $229.22 million, reflecting a 6% increase from the prior-year quarter [4] - 'Revenues- Resident fees and services' are expected to total $1.11 billion, showing a year-over-year increase of 23.4% [5] Depreciation and Returns - Analysts project 'Depreciation and amortization' to be approximately $361.19 million [5] - Over the past month, shares of Ventas have returned +1.3%, compared to a +1.8% change in the Zacks S&P 500 composite [5] - With a Zacks Rank of 4 (Sell), VTR is expected to underperform the overall market in the near future [5]
Ventas (VTR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-07-30 23:31
Core Insights - Ventas reported revenue of $1.42 billion for the quarter ended June 2025, marking an 18.3% increase year-over-year, with EPS at $0.87 compared to $0.05 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $1.37 billion, resulting in a surprise of +3.47%, while the EPS also surpassed the consensus estimate of $0.85 by +2.35% [1] Revenue Breakdown - Resident fees and services generated $1.03 billion, exceeding the average estimate of $977.05 million, reflecting a year-over-year increase of +26.3% [4] - Interest and other income amounted to $5.87 million, surpassing the average estimate of $2.98 million, with a year-over-year change of +21.7% [4] - Rental income from outpatient medical & research portfolio was $220.81 million, slightly below the average estimate of $222.56 million, showing a +0.9% year-over-year change [4] - Income from loans and investments reached $4.4 million, exceeding the average estimate of $4.31 million, with a significant year-over-year increase of +206.1% [4] - Total rental income was $373.52 million, slightly below the average estimate of $376.31 million [4] - Third-party capital management revenues were $4.4 million, in line with the average estimate of $4.38 million, reflecting a +1.5% change year-over-year [4] - Rental income from triple-net leased properties was $152.7 million, slightly below the average estimate of $153.51 million, indicating a -0.8% change year-over-year [4] - Net Earnings Per Share (Diluted) was reported at $0.15, exceeding the average estimate of $0.13 [4] Stock Performance - Ventas shares have returned +6.3% over the past month, outperforming the Zacks S&P 500 composite's +3.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]